Low-FODMAP diet risks: who should not start it alone
The risks of the low-FODMAP diet, who should not self-start it, why the AGA caps the strict phase at 4 to 6 weeks, and what to settle with a doctor or dietitian first.
Gutli is made by Lucernel.

On this page
Short answer
The low-FODMAP diet is a recognized short trial for irritable bowel syndrome, not a diet to start alone or to keep for life. The American Gastroenterological Association (AGA) says to restrict for no more than 4 to 6 weeks, then reintroduce foods, and it names people with an eating disorder, a risk of malnutrition or food insecurity as poor candidates. Children and older adults need extra care. See a clinician first.
Choose this if
A short, planned trial agreed with your doctor or dietitian is reasonable if IBS has been diagnosed and certain foods clearly set off your symptoms.
Choose the other option if
Skip it, or wait for a clinician, if you have not been diagnosed, have warning signs, live with an eating disorder or are buying food on a tight budget.
At a glance
| Feature | Starting alone from a food list | Clinician-led trial logged in Gutli |
|---|---|---|
| Checks that IBS is the right explanation | Nosymptoms may have another cause | Yesyour doctor decides; Gutli does not diagnose |
| Screens for eating disorder or nutrition risk | No | Nothat is for your clinician or dietitian |
| Has an end date | Partlyeasy to drift on for months | Partlyyou move between phases yourself, so agree the end date first |
| Records meals and symptoms together | Partlymemory or loose notes | Yesmeals with portions and symptom and Bristol check-ins on one timeline |
| Tracks the three phases | No | Yeselimination, reintroduction and maintenance, with transitions you control |
| Gives your clinician something to read | No | Yesa PDF or CSV report |
What the risks are
The diet removes whole groups of foods, so the main risks come from restriction itself. A 2024 review in The Lancet Gastroenterology and Hepatology says whole-diet interventions that restrict intake can be challenging to deliver effectively and safely, and that there is concern about a role in eating disorder risk. It adds that inappropriate use or inadequate monitoring can risk poor nutrient intake.
A 2017 review in Gut reports that the diet led to a clinical response in 50% to 80% of patients with IBS in at least 10 randomised trials. The same review notes profound changes in the gut microbiota and metabolome, and says the duration and clinical relevance of those changes are not known yet. The Lancet review adds that cost is a practical risk: in one 4-week trial, 82% of patients said the low-FODMAP diet and a gluten-free diet were more expensive than their usual diet.
Who should not start it alone
The American Gastroenterological Association's 2022 practice update names the people who are poor candidates for restrictive diets: those eating few culprit foods, those at risk of malnutrition, those who are food insecure, and those with an eating disorder or an uncontrolled psychiatric disorder. It calls routine screening for disordered eating, by careful dietary history, critical, because eating disorders are common and often overlooked in gastrointestinal conditions.
The Lancet review puts the estimated prevalence of a possible current eating disorder in adults with IBS between 2% and 29%, and a past diagnosed eating disorder between 9% and 17%. In a London study of 233 people starting a low-FODMAP group programme, 23% screened as at risk for eating disorder behavior, and 57% of them adhered to the diet against 35% of the others.
Children are a separate case. An ESPGHAN position paper from 2022 found scarce evidence for the diet in children with IBS and none for other digestive complaints, and warns that a restrictive diet may impact nutritional adequacy or promote distorted eating in vulnerable children. The Lancet review says restrictive diets in older adults should generally be recommended with caution because of altered nutritional needs and the risk of malnutrition.
If you are pregnant or manage another condition with food, ask your clinician before restricting anything. That is our own advice, not a guideline statement.
Get the diagnosis before the diet
The American College of Gastroenterology guideline suggests a positive diagnostic strategy for IBS instead of diagnosis by exclusion, with celiac serology for people with IBS and diarrhea, and a fecal calprotectin test in people with suspected IBS and diarrhea, to rule out inflammatory bowel disease. It then recommends a limited trial of a low-FODMAP diet to improve global symptoms.
NIDDK lists symptoms that may point to another health problem instead of IBS: anemia, rectal bleeding, bloody or black and tarry stools, and weight loss. Do not use a food diary or a diet to explain those. Tell a doctor.
Keep it short and finish the plan
The AGA says the diet has three phases: restriction lasting no more than 4 to 6 weeks, reintroduction of FODMAP foods, and personalization. It also says any diet intervention should run for a predetermined length of time, and if there is no clinical response, it should be abandoned for another treatment. NIDDK likewise describes trying it for a few weeks and then slowly adding foods back.
Support matters. The Lancet review says that in a Canadian survey of 80 patients, fewer reached the therapeutic FODMAP target when they had no dietitian support, and that many drawbacks of whole-diet interventions can be reduced by advice from a dietitian who knows IBS.
Warning signs during the diet
The Lancet review describes eating disorder symptoms as dietary restriction, limited variety or long periods without eating, preoccupation with rules about what to eat, and considerable fear or guilt about food. Weight loss and nutrient deficiencies can follow, and some effects, such as lower bone density, may not be reversible.
If any of that sounds familiar, or if you are losing weight without trying, stop restricting and call your doctor or dietitian. If logging every bite starts to feel stressful, stop the logging too. This is our own advice.
Frequently asked questions
Is the low-FODMAP diet safe?
It is considered a short trial under guidance. The AGA caps the strict phase at 4 to 6 weeks, and names eating disorders, malnutrition risk and food insecurity as reasons to avoid restriction.
How long can you stay on a low-FODMAP diet?
The AGA says restriction should last no more than 4 to 6 weeks, followed by reintroduction and personalization. It is not meant to be permanent.
Can children follow the low-FODMAP diet?
Only with specialist guidance. ESPGHAN found scarce evidence in children with IBS and warns about nutritional adequacy and distorted eating.
Should I try it if I have an eating disorder?
The AGA lists an eating disorder as a reason to avoid restrictive diets. Talk to your treatment team first.
Is Gutli available?
See the official app page for current availability and pricing.
Our pick
Gutli, a record to bring to your clinician
If your doctor or dietitian agrees a trial, Gutli keeps the daily part simple: meals with portions, symptom and Bristol check-ins, and the three phases with transitions you control. Weekly and monthly summaries and a PDF or CSV report give your clinician something to read. Gutli records and shows patterns with their confidence. It does not diagnose, screen for eating disorders or replace a dietitian.
- Elimination, reintroduction and maintenance phases
- Meals and symptoms on one timeline
- Clinician-ready PDF or CSV report
Sources · checked October 1, 2026
- ACG Clinical Guideline: Management of Irritable Bowel Syndrome (PubMed, 2021)
- AGA Clinical Practice Update on the Role of Diet in IBS (PubMed, 2022)
- The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS (Gut, 2017, PubMed)
- Dietary management of irritable bowel syndrome: considerations, challenges, and solutions (Lancet Gastroenterol Hepatol, 2024, PMC)
- Adherence with a low-FODMAP diet in IBS: are eating disorders the missing link? (PubMed, 2019)
- ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology (PubMed, 2022)
- NIDDK: Eating, Diet, & Nutrition for Irritable Bowel Syndrome
- NIDDK: Diagnosis of Irritable Bowel Syndrome
















